Two distinct discoveries are recognised for the 2024 Chemistry Nobel Prize, yet as you shall see, they are closely related. We must go all the way back to the early days of modern biochemistry in order to comprehend the struggles that this year’s laureates have faced.
The discovery of a crucial regulatory mechanism that cells utilize to regulate gene activity is the main focus of this year’s Nobel Prize.
However, it’s also known that TET2 mutations can result in conditions other than cancer. A portion of persons over the age of 70 also had TET2 mutations, which raise the risk of diabetes, heart disease, stroke, and other inflammatory diseases as well as CHIP.
Brain lesions produced by major brain trauma or stroke can alter neuronal connections between the motor cortex, a critical brain area needed for coordinating voluntary movement, and the muscles.
The outcomes of an international Phase III clinical trial conducted by researchers from the University of Pennsylvania Perelman School of Medicine and a multicenter group [Read More…]
The report states that vascular dementia is the second most frequent subtype of dementia after Alzheimer’s disease. Still, the two illnesses are different clinically.
Findings could inform artificial intelligence research by helping investigators determine how one could develop more distributed neural networks.
A Phase 1/2 trial included 15 individuals in total, among them three pediatric patients. The patients all suffered from the disease Leber congenital amaurosis caused by a gene that is essential in making proteins crucial to vision.
The rates of heart failure events and cardiovascular death were lower in the finerenone group compared with the placebo group.
This new research, published in Alzheimer’s & Dementia, suggested that the cognitive impairments of COVID-19 presented similar fundamental changes within the brain to those showing evidence of dementia.
